NRI from all over the world (excluding U.S.A. & Canada) can invest in this fund
SBNRI is a certified Mutual Fund distributor registered with Association of Mutual Funds in India (AMFI) with Reg. No. 246671
₹15.90
1.07%
NAV as on 19 Nov 24, 12:00 AM
very high risk
sector healthcare
equity
NAV as on 19 Nov 24, 12:00 AM
very high risk
sector healthcare
equity
50.99%p.a.
Last 1Y
0.00%p.a.
Last 3Y
0.00%p.a.
Last 5Y
57.82%p.a.
Since Inception
NRIs can achieve long-term capital appreciation by investing in the HDFC Pharma and Healthcare Fund Growth scheme from HDFC Asset Management Co Ltd. It is a Sector - Healthcare mutual fund scheme that predominantly invests in Sector - Healthcare stocks of companies. Launched on Oct 2023, HDFC Pharma and Healthcare Fund Growth is Sector - Healthcare fund of its category with 1,382.6 Cr fund under management as on Nov 2024. The expense ratio of this fund is less than that of most other Fund category Sector - Healthcare funds.
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.
Sun Pharmaceuticals Industries Ltd
14.02%
Cipla Ltd
8.17%
Divi's Laboratories Ltd
7.91%
Lupin Ltd
6.25%
Ipca Laboratories Ltd
4.08%
Gland Pharma Ltd
4.00%
Aurobindo Pharma Ltd
3.44%
Piramal Pharma Ltd
3.41%
Dr Reddy's Laboratories Ltd
3.32%
Eris Lifesciences Ltd Registered Shs
3.27%
View Scheme Document
If invested
per month
For a period of
Investment of ₹0 could have been
₹0(+0.0%)
₹0 (+0.0%)
This Fund
₹0 (+0.0%)
Fixed Deposit
Just like for resident investors, capital gains from mutual fund investments are subject to income tax for NRI investors.
Fund Type | Short-term Capital Gains (STCG) Tax | Long-term Capital Gains (LTCG) Tax |
---|---|---|
Equity mutual funds | 15% | 10% (above Rs. 1 lakh LTCG) without indexation* |
Debt & other types of funds | At tax slab rate | 20% with indexation benefits |
NRIs and OCIs can download the SBNRI app to invest in mutual funds from the country of their residence. Here are a few simple steps you need to take:
If all details are correct, your KYC will be approved within 7 to 8 business days.
Funds
3Y Return
very high risk | equity
18.3%
very high risk | equity
23.2%
very high risk | equity
22.9%